Medical device manufacturers selling in Europe are legally obligated to report adverse events, incidents, and recalls, also known as vigilance reporting. Yet European authorities suspect that underreporting is a widespread issue.
Vigilance reporting is confusing for many manufacturers active in European markets but it is critical to comply with vigilance requirements. In this whitepaper, we'll answer your biggest questions about vigilance reporting, including:
You'll learn all this and more in this 7-page white paper.
About the Author:
Evangeline Loh, Ph.D., RAC (US/EU): Evangeline is Vice President of Global Regulatory Affairs at Emergo. Evangeline’s areas of expertise include European CE Marking, clinical evaluation reports, vigilance, and device classification in markets worldwide. She previously worked for Cook Medical and holds a Ph.D. in pharmacology from The University of Texas Health Sciences Center at San Antonio.
我们的专家将详细解读2023年韩国食品药品安全部(MFDS)指导文件草案更新下韩国医疗器械注册监管要求、分类标准、韩国良好生产规范(KGMP)等相关要求,并将依据多年韩国本地注册经验提供注册案例分享。此外,您还将了解到制造商在面对MFDS监管时需要关注的核心要点,相关研讨会内容包括:
阅读更多